Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years.
Saved in:
| Title: | Serum metabolic profile at clinical onset as predictor of multiple sclerosis activity and progression after 5 years. |
|---|---|
| Authors: | Peng X; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Bjornevik K; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Clish CB; Metabolomics Platform, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Edan G; CHU Hôpital Pontchaillou, Rennes, France., Freedman MS; Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, Ottawa, ON, Canada., Hartung HP; Department of Neurology, Medical Faculty, Heinrich-Heine Universität, Düsseldorf, Germany; Brain and Mind Center, Medical Faculty, The University of Sydney, Sydney NSW, Australia; Brain and Mind Centre, The University of Sydney, Sydney NSW, Australia; Department of Neurology, Palacky University Olomouc, Olomouc, Czechia., Montalbán X; Multiple Sclerosis Center of Catalonia (Cemcat), Vall d'Hebron University Hospital, Barcelona, Spain., Sandbrink R; Department of Neurology, Medical Faculty, Heinrich-Heine Universität, Düsseldorf, Germany; Sandbrink Drug Development Consulting & Clinical Services (SDDCCS), Berlin, Germany., Kuhle J; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital Basel, University of Basel, Basel, Switzerland., Barkhof F; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, UK., Wicklein EM; Bayer AG, Berlin, Germany., Kappos L; Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital Basel, University of Basel, Basel, Switzerland., Ascherio A; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA., Cortese M; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2026 Jun; Vol. 32 (7), pp. 696-710. Date of Electronic Publication: 2026 Apr 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
